Amgen, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0311621009
USD
344.75
54.77 (18.89%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
9,585.00
9,167.00
8,093.00
9,045.00
8,458.00
8,333.00
7,396.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
9,585.00
9,167.00
8,093.00
9,045.00
8,458.00
8,333.00
7,396.00
Raw Material Cost
3,082.00
3,011.00
2,968.00
1,536.00
3,310.00
3,236.00
3,200.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
698.00
708.00
739.00
747.00
791.00
826.00
845.00
Selling and Distribution Expenses
1,720.00
1,691.00
1,687.00
1,819.00
1,625.00
1,785.00
1,808.00
Other Expenses
120.20
103.60
74.70
95.10
65.90
62.10
49.80
Total Expenditure (Excl Depreciation)
6,702.00
6,446.00
6,141.00
5,053.00
6,385.00
6,468.00
6,351.00
Operating Profit (PBDIT) excl Other Income
2883
2721
1952
3992
2073
1865
1045
Other Income
2,052.00
-382.00
1,574.00
-903.00
1,875.00
-252.00
-184.00
Operating Profit (PBDIT)
5,913.00
3,603.00
4,083.00
4,425.00
5,273.00
3,002.00
2,155.00
Interest
698.00
708.00
739.00
747.00
791.00
826.00
845.00
Exceptional Items
13.00
14.00
16.00
-1,646.00
15.00
18.00
21.00
Gross Profit (PBDT)
6,503.00
6,156.00
5,125.00
7,509.00
5,148.00
5,097.00
4,196.00
Depreciation
1,307.00
1,341.00
1,387.00
1,397.00
1,396.00
1,400.00
1,399.00
Profit Before Tax
3,921.00
1,568.00
1,973.00
782.00
3,101.00
794.00
-68.00
Tax
705.00
136.00
243.00
155.00
271.00
48.00
45.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3,216.00
1,432.00
1,730.00
627.00
2,830.00
746.00
-113.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3,216.00
1,432.00
1,730.00
627.00
2,830.00
746.00
-113.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3,216.00
1,432.00
1,730.00
627.00
2,830.00
746.00
-113.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
9,619.00
7,428.00
6,207.00
5,877.00
7,527.00
5,925.00
5,022.00
Earnings per share (EPS)
5.93
2.65
3.2
1.16
5.22
1.38
-0.21
Diluted Earnings per share
5.93
2.65
3.2
1.16
5.22
1.38
-0.21
Operating Profit Margin (Excl OI)
26.65%
28.84%
13.86%
43.46%
23.67%
22.25%
12.71%
Gross Profit Margin
54.54%
31.73%
41.52%
24.09%
53.17%
26.33%
18.0%
PAT Margin
33.55%
15.62%
21.38%
6.93%
33.46%
8.95%
-1.53%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 13.32% vs 23.11% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 13.64% vs 63.58% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 13.63% vs 17.86% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is -11.76% vs 1.41% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Amgen, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
9,585.00
7,784.00
1,801.00
23.14%
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,585.00
7,784.00
1,801.00
23.14%
Raw Material Cost
3,082.00
1,569.00
1,513.00
96.43%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
698.00
256.00
442.00
172.66%
Selling and Distribution Expenses
1,720.00
1,352.00
368.00
27.22%
Other Expenses
120.20
107.80
12.40
11.50%
Total Expenditure (Excl Depreciation)
6,702.00
4,255.00
2,447.00
57.51%
Operating Profit (PBDIT) excl Other Income
2,883.00
3,529.00
-646.00
-18.31%
Other Income
2,052.00
50.00
2,002.00
4,004.00%
Operating Profit (PBDIT)
5,913.00
4,265.00
1,648.00
38.64%
Interest
698.00
256.00
442.00
172.66%
Exceptional Items
13.00
317.00
-304.00
-95.90%
Gross Profit (PBDT)
6,503.00
6,215.00
288.00
4.63%
Depreciation
1,307.00
686.00
621.00
90.52%
Profit Before Tax
3,921.00
3,641.00
280.00
7.69%
Tax
705.00
589.00
116.00
19.69%
Provisions and contingencies
0
0
0.00
Profit After Tax
3,216.00
3,052.00
164.00
5.37%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
3,216.00
3,052.00
164.00
5.37%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3,216.00
3,052.00
164.00
5.37%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
9,619.00
21,540.00
-11,921.00
-55.34%
Earnings per share (EPS)
5.93
2.43
3.50
144.03%
Diluted Earnings per share
5.93
2.43
3.50
144.03%
Operating Profit Margin (Excl OI)
26.65%
45.34%
0.00
-18.69%
Gross Profit Margin
54.54%
55.59%
0.00
-1.05%
PAT Margin
33.55%
39.21%
0.00
-5.66%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 958.50 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 4.56% vs 13.27% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 13.32% vs 23.11% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 321.60 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 124.58% vs -17.23% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 13.64% vs 63.58% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 386.10 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -3.11% vs 58.83% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 13.63% vs 17.86% in Sep 2024

Quarterly - Interest
Interest 69.80 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -1.41% vs -4.19% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -11.76% vs 1.41% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.65%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024